Krishna Bhat received his PhD from the University of Illinois at Chicago, followed by a post-doctoral fellowship at the MD Anderson Cancer Center. He is currently an Assistant Professor in the Departments of Translational Molecular Pathology and Neurosurgery at MD Anderson. He is an active member of the Brain Tumor Center Executive Committee, a Project Leader in the GBM Moon Shots Initiative, and serves as the co-Director of the Career Enhancement Program Award of the Brain SPORE. His laboratory uses multi-pronged approaches to elucidate the genetic, molecular, and immunological drivers of glioblastoma. Dr. Bhat has made significant contributions to the field by identifying that master regulators that promote mesenchymal transition and treatment resistance in glioblastoma. Recently he is developing tumor educated platelets and cfDNA methylation as a liquid biopsy platform to monitor glioblastoma progression. A third emerging area of research interest in his laboratory is to characterize the brain tumor microenvironment using deep immunophenotyping approaches. His laboratory is funded by grants from the NIH and DoD. He is a recipient of multiple accolades and of note the Adult Basic Science award from the Society of Neuro-oncology.